New England Journal of Medicine
Medical marijuana: Voodoo or legitimate therapeutic choice?
(HealthDay)—Imagine a 68-year-old woman with advanced breast cancer, looking for a better way to ease her chronic pain, low appetite, fatigue and nausea. Should she or shouldn't she be prescribed marijuana?
Medications
Feb 21, 2013 |
3 / 5 (6) |
12
Report discusses impact of ACGME 2011 requirements
(HealthDay)—Although many residency program directors approve of individual components within the Accreditation Council for Graduate Medical Education (ACGME) Common Program Requirements introduced in 2011, ...
Other
Feb 21, 2013 |
not rated yet |
0
New blood thinner beats older drug for vein clots
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications
Feb 20, 2013 |
4 / 5 (1) |
0
|
US doctors slow to adopt electronic health records
(HealthDay)—Although doctors who are using electronic health records in a meaningful way are eligible for a $44,000 bonus from the U.S. government, many still haven't adopted the new technology, a new study ...
Health
Feb 20, 2013 |
not rated yet |
0
Bracelet-like device controls chronic acid reflux, study finds
A bracelet-like device with magnetic beads can control the chronic digestive disorder gastroesophageal reflux disease, according to a study published online today in the New England Journal of Medicine.
Diseases, Conditions, Syndromes
Feb 20, 2013 |
not rated yet |
0
|
Oregon experiment will provide insight into ACO-based reform
(HealthDay)—The outcome of the Oregon experiment, an ambitious program centered on a model of an accountable care organization (ACO), will offer important lessons for the wider implementation of ACOs as ...
Health
Feb 14, 2013 |
not rated yet |
1
Parkinson's patients advised to seek Deep Brain Stimulation treatment in early stages
People with Parkinson's disease who receive Deep Brain Stimulation (DBS) therapy in the early stages of the condition will benefit from a significant increase in quality of life, a revolutionary study from ...
Neuroscience
Feb 14, 2013 |
not rated yet |
0
Drug shown to reverse radioiodine resistance in some advanced thyroid cancers
The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan-Kettering ...
Cancer
Feb 14, 2013 |
not rated yet |
0
Study reveals clues to childhood respiratory virus
New Vanderbilt-led research published in the Feb. 14 issue of the New England Journal of Medicine has identified the relatively unknown human metapneumovirus (MPV) as the second most common cause of severe bronchiolitis in you ...
Diseases, Conditions, Syndromes
Feb 13, 2013 |
not rated yet |
0
|
Imaging acute ischemic stroke patients' brains did not lead to improved outcomes
The use of advanced imaging shortly after the onset of acute stroke failed to identify a subgroup of patients who could benefit from a clot-removal procedure, a study has found.
Cardiology
Feb 08, 2013 |
not rated yet |
0
|
Comparing mechanical clot removal and standard medical therapy for severe stroke
Results of the first randomized controlled study to evaluate a procedure that removes blood clots in the brain from patients experiencing severe strokes will be presented at the International Stroke Conference in Honolulu, ...
Cardiology
Feb 08, 2013 |
not rated yet |
0
'Clot-buster' drug may still be best stroke treatment
(HealthDay)—The standard medical care for patients having an ischemic stroke is to give powerful "clot-busting" drugs as soon as possible after the start of the stroke.
Cardiology
Feb 07, 2013 |
not rated yet |
0
Clot-retrieval devices failed to improve stroke-related disability
A stroke survivor's chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according ...
Cardiology
Feb 07, 2013 |
not rated yet |
0
Pertactin-negative Bordetella pertussis identified in U.S.
(HealthDay)—Pertactin-negative variants of Bordetella pertussis have been identified in the United States; and children who receive diphtheria-tetanus-whole-cell pertussis (DTwP) priming have lower report ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
Rivaroxaban found noninferior to enoxaparin in acutely ill
(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has ...
Diseases, Conditions, Syndromes
Feb 07, 2013 |
not rated yet |
0
